Home › Research › How common it is
Lipoprotein(a) and risk of dementia: findings from three cohort studies
Peter Engel Thomas, Signe Vedel‐Krogh, Sune Fallgaard Nielsen, Børge Grønne Nordestgaard, Ruth Frikke‐Schmidt, Pia R. Kamstrup. European Heart Journal, 2025-06-17
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
On continuous scales, lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia. When accounting for competing risk of death, absolute risks of vascular-related dementia increased with higher lipoprotein(a) levels in the UK Biobank (n = 452 989; events = 5132; P = .01), but not in the Copenhagen studies (n = 80 313; events = 2734; P = .42). In the Copenhagen studies, LPA KIV-2 number of repeats ≤5th vs > 50th percentiles associated with a subdistribution hazard ratio for Alzheimer's disease of 1.25 (95% confidence interval, 1.06-1.46). Low lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia. It cannot be excluded that very high lipoprotein(a) or small isoform size increases the risk of dementia.
What this study adds
Evidence grade: Low
The record lists 452 participants. Across three cohort studies, lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia on continuous scales. The authors state it cannot be excluded that very high lipoprotein(a) or small isoform size increases dementia risk.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Thomas, P. E., Vedel‐Krogh, S., Nielsen, S. F., Nordestgaard, B. G., Frikke‐Schmidt, R., & Kamstrup, P. R. (2025). Lipoprotein(a) and risk of dementia: findings from three cohort studies. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaf465
Vancouver
Thomas PE, Vedel‐Krogh S, Nielsen SF, Nordestgaard BG, Frikke‐Schmidt R, Kamstrup PR. Lipoprotein(a) and risk of dementia: findings from three cohort studies. European Heart Journal. 2025. doi:10.1093/eurheartj/ehaf465. PMID: 40824531.
BibTeX
@article{thomas2025-40824531,
author = {Thomas, Peter Engel and Vedel‐Krogh, Signe and Nielsen, Sune Fallgaard and Nordestgaard, Børge Grønne and Frikke‐Schmidt, Ruth and Kamstrup, Pia R.},
title = {{Lipoprotein(a) and risk of dementia: findings from three cohort studies}},
journal = {European Heart Journal},
year = {2025},
doi = {10.1093/eurheartj/ehaf465},
pmid = {40824531},
url = {https://doi.org/10.1093/eurheartj/ehaf465}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- On continuous scales, lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia.
- When accounting for competing risk of death, absolute risks of vascular-related dementia increased with higher lipoprotein(a) levels in the UK Biobank (n = 452 989; events = 5132; P = .01), but not in the Copenhagen studies (n = 80 313; events = 2734; P = .42).
- In the Copenhagen studies, LPA KIV-2 number of repeats ≤5th vs > 50th percentiles associated with a subdistribution hazard ratio for Alzheimer's disease of 1.25 (95% confidence interval, 1.06-1.46).
- Low lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia.
- It cannot be excluded that very high lipoprotein(a) or small isoform size increases the risk of dementia.
Why it matters
Across three cohort studies, lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia on continuous scales. The authors state it cannot be excluded that very high lipoprotein(a) or small isoform size increases dementia risk.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Participants452
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (European Heart Journal) |
| Journal's citation record | 3 / 4 | European Heart Journal: journal h-index 456 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 452 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 9 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 5.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Pia R. Kamstrup: h-index 49 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Copenhagen: institution h-index 1,378 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40824531) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in How common it is from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.